4//SEC Filing
Poole Sandra 4
Accession 0001209191-22-028701
CIK 0001438533other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 8:33 PM ET
Size
7.3 KB
Accession
0001209191-22-028701
Insider Transaction Report
Form 4
Poole Sandra
Director
Transactions
- Award
Common Stock
2022-05-11+3,000→ 12,500 total - Award
Stock option (right to buy)
2022-05-11+9,000→ 9,000 totalExercise: $21.38From: 2023-05-11Exp: 2032-05-10→ Common Stock (9,000 underlying)
Footnotes (2)
- [F1]Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.
- [F2]The equity award vests over a one year period.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001619622
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 8:33 PM ET
- Size
- 7.3 KB